Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Evaluation of Radiotherapy and Response in the Management of Perivascular Epithelioid Cell Tumors.

The British journal of radiology·2026
Same author

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors: Erratum.

The Journal of urology·2026
Same author

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses.

Science advances·2026
Same author

A Bayesian Causal Model for Matrix-Valued Exposures With Applications to Radiotherapy Planning.

Statistics in medicine·2026

Related Experiment Video

Updated: Apr 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Deriving patient-specific planning target volume for partial bladder image guided radiation therapy.

Vickie Kong1, Tara Rosewall2, Susan Chen1

  • 1Radiation Medicine Program, Princess Margaret Cancer Center, Toronto, Canada.

Practical Radiation Oncology
|September 7, 2014
PubMed
Summary

This study introduces a new method using lipiodol and cone beam computed tomography (CBCT) to create patient-specific planning target volumes (PS-PTV) for bladder cancer radiation therapy. This approach significantly reduces irradiated normal tissue while ensuring complete tumor coverage.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.2K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

13.9K

Related Experiment Videos

Last Updated: Apr 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.2K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

13.9K

Area of Science:

  • Radiation Oncology
  • Medical Imaging
  • Urological Cancer Treatment

Background:

  • Image-guided radiation therapy (IGRT) for bladder cancer often uses large planning target volume (PTV) margins due to geometric uncertainties.
  • These large margins can lead to unnecessary irradiation of surrounding healthy tissues.
  • Accurate identification of the clinical target volume (CTV) is challenging in bladder cancer treatment.

Purpose of the Study:

  • To describe a novel method for deriving patient-specific PTV (PS-PTV) for partial bladder IGRT.
  • To evaluate the efficacy of using lipiodol and CBCT in creating PS-PTV.
  • To reduce the volume of irradiated normal tissue while maintaining target coverage in bladder cancer patients.

Main Methods:

  • Lipiodol was injected into the bladder wall of 12 patients prior to radiation therapy.
  • Patient-specific PTV (PS-PTV) was generated by delineating CTV on 15 CBCTs, registering CBCTs to planning CT using lipiodol, creating an occupancy volume (OV) from CTVs, and expanding the OV by 3 mm.
  • The PS-PTV was compared to a 20-mm population-based PTV (popPTV) for efficacy in reducing irradiated volume and ensuring coverage.

Main Results:

  • The median PS-PTV (102 cm³) was substantially smaller than the median popPTV (325 cm³).
  • Significant reductions in the overlapping volumes of the rectum (0.3 cm³), small bowel (5.3 cm³), and large bowel (13.0 cm³) were observed.
  • The PS-PTV method achieved 100% target coverage, despite reductions in volume and margin compared to the popPTV.

Conclusions:

  • The use of lipiodol and CBCT to derive PS-PTV is effective for partial bladder IGRT.
  • This technique allows for significant reductions in irradiated normal tissue volume.
  • The PS-PTV approach maintains adequate target coverage, improving treatment precision for bladder cancer.